Literature DB >> 18991865

Chronic low-dose oxidative stress induces caspase-3-dependent PKCdelta proteolytic activation and apoptosis in a cell culture model of dopaminergic neurodegeneration.

Martha Carvour1, Chunjuan Song, Siddharth Kaul, Vellareddy Anantharam, Anumantha Kanthasamy, Arthi Kanthasamy.   

Abstract

Oxidative stress has been implicated as a key event in the degenerative process of dopaminergic neurons; however, the cellular mechanisms underlying chronic oxidative stress-induced neurodegeneration remain to be established. In this study, N27 cells, a dopaminergic neuronal cell line derived from rat mesencephalon, exposed to low doses of H(2)O(2) (0-30 muM for 12-24 hr) exhibited dose- and time-dependent increases in cytotoxicity and ROS generation. In addition, the H(2)O(2)-induced neurotoxicity was accompanied by increased caspase-3 activity and PKCdelta cleavage. Notably, treatment with antioxidants Trolox and MnTBAP or PKCdelta cleavage inhibitor z-DIPD-fmk significantly protected against oxidative stress-induced apoptotic cell death. These results demonstrate that the N27 cell line is a useful model for the study of the chronic low-dose oxidative stress-induced apoptotic cell death cascade and that caspase-3-dependent PKCdelta proteolytic activation may be important in the apoptotic process in dopaminergic neurons undergoing chronic oxidative insult.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991865      PMCID: PMC2657189          DOI: 10.1196/annals.1432.020

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  32 in total

1.  Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.

Authors:  H Turmel; A Hartmann; K Parain; A Douhou; A Srinivasan; Y Agid; E C Hirsch
Journal:  Mov Disord       Date:  2001-03       Impact factor: 10.338

2.  Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease.

Authors:  A Hartmann; S Hunot; P P Michel; M P Muriel; S Vyas; B A Faucheux; A Mouatt-Prigent; H Turmel; A Srinivasan; M Ruberg; G I Evan; Y Agid; E C Hirsch
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain.

Authors:  B L Roth; M Poot; S T Yue; P J Millard
Journal:  Appl Environ Microbiol       Date:  1997-06       Impact factor: 4.792

4.  Protein kinase C delta is essential for etoposide-induced apoptosis in salivary gland acinar cells.

Authors:  M E Reyland; S M Anderson; A A Matassa; K A Barzen; D O Quissell
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

5.  Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, is mediated by activation of caspase 3.

Authors:  Y Akao; Y Nakagawa; W Maruyama; T Takahashi; M Naoi
Journal:  Neurosci Lett       Date:  1999-06-04       Impact factor: 3.046

6.  Dopaminergic cell death induced by MPP(+), oxidant and specific neurotoxicants shares the common molecular mechanism.

Authors:  H S Chun; G E Gibson; L A DeGiorgio; H Zhang; V J Kidd; J H Son
Journal:  J Neurochem       Date:  2001-02       Impact factor: 5.372

7.  Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson's disease. The effect of dopaminergic treatment.

Authors:  F Blandini; M Cosentino; A Mangiagalli; F Marino; A Samuele; E Rasini; R Fancellu; C Tassorelli; C Pacchetti; E Martignoni; G Riboldazzi; D Calandrella; S Lecchini; G Frigo; G Nappi
Journal:  J Neural Transm (Vienna)       Date:  2004-03-19       Impact factor: 3.575

8.  The pesticide rotenone induces caspase-3-mediated apoptosis in ventral mesencephalic dopaminergic neurons.

Authors:  Ferogh A Ahmadi; Daniel A Linseman; Tom N Grammatopoulos; Susan M Jones; Ron J Bouchard; Curt R Freed; Kim A Heidenreich; W Michael Zawada
Journal:  J Neurochem       Date:  2003-11       Impact factor: 5.372

Review 9.  Role of proteolytic activation of protein kinase Cdelta in oxidative stress-induced apoptosis.

Authors:  Anumantha G Kanthasamy; Masashi Kitazawa; Arthi Kanthasamy; Vellareddy Anantharam
Journal:  Antioxid Redox Signal       Date:  2003-10       Impact factor: 8.401

10.  Suppression of caspase-3-dependent proteolytic activation of protein kinase C delta by small interfering RNA prevents MPP+-induced dopaminergic degeneration.

Authors:  Yongjie Yang; Siddharth Kaul; Danhui Zhang; Vellareddy Anantharam; Anumantha G Kanthasamy
Journal:  Mol Cell Neurosci       Date:  2004-03       Impact factor: 4.314

View more
  23 in total

1.  Oxidative stress defines the neuroprotective or neurotoxic properties of androgens in immortalized female rat dopaminergic neuronal cells.

Authors:  Shaletha Holmes; Babak Abbassi; Chang Su; Meharvan Singh; Rebecca L Cunningham
Journal:  Endocrinology       Date:  2013-08-19       Impact factor: 4.736

2.  Effects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell Line.

Authors:  Shaletha Holmes; Meharvan Singh; Chang Su; Rebecca L Cunningham
Journal:  Endocrinology       Date:  2016-05-11       Impact factor: 4.736

3.  Transformer 2β homolog (Drosophila) (TRA2B) regulates protein kinase C δI (PKCδI) splice variant expression during 3T3L1 preadipocyte cell cycle.

Authors:  Rekha S Patel; Gay Carter; Denise R Cooper; Hercules Apostolatos; Niketa A Patel
Journal:  J Biol Chem       Date:  2014-09-26       Impact factor: 5.157

4.  Differential effects of ethanol on bid, tBid, and Bax:tBid interactions in postnatal day 4 and postnatal day 7 rat cerebellum.

Authors:  Marieta B Heaton; Michael Paiva; Stacey Kubovec
Journal:  Alcohol Clin Exp Res       Date:  2015-01       Impact factor: 3.455

Review 5.  The effect of environmental chemicals on the tumor microenvironment.

Authors:  Stephanie C Casey; Monica Vaccari; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Mary Helen Barcellos-Hoff; Dustin G Brown; Marion Chapellier; Joseph Christopher; Colleen S Curran; Stefano Forte; Roslida A Hamid; Petr Heneberg; Daniel C Koch; P K Krishnakumar; Ezio Laconi; Veronique Maguer-Satta; Fabio Marongiu; Lorenzo Memeo; Chiara Mondello; Jayadev Raju; Jesse Roman; Rabindra Roy; Elizabeth P Ryan; Sandra Ryeom; Hosni K Salem; A Ivana Scovassi; Neetu Singh; Laura Soucek; Louis Vermeulen; Jonathan R Whitfield; Jordan Woodrick; Annamaria Colacci; William H Bisson; Dean W Felsher
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

6.  PKCδ mediates paraquat-induced Nox1 expression in dopaminergic neurons.

Authors:  Ana Clara Cristóvão; Joana Barata; Goun Je; Yoon-Seong Kim
Journal:  Biochem Biophys Res Commun       Date:  2013-07-02       Impact factor: 3.575

7.  PI3K/Akt and caspase pathways mediate oxidative stress-induced chondrocyte apoptosis.

Authors:  Dong Li; Su Ni; Kai-Song Miao; Chao Zhuang
Journal:  Cell Stress Chaperones       Date:  2018-12-13       Impact factor: 3.667

Review 8.  Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes.

Authors:  Huajun Jin; Arthi Kanthasamy; Anamitra Ghosh; Vellareddy Anantharam; Balaraman Kalyanaraman; Anumantha G Kanthasamy
Journal:  Biochim Biophys Acta       Date:  2013-09-20

9.  Prolonged exposure of cortical neurons to oligomeric amyloid-β impairs NMDA receptor function via NADPH oxidase-mediated ROS production: protective effect of green tea (-)-epigallocatechin-3-gallate.

Authors:  Yan He; Jiankun Cui; James C-M Lee; Shinghua Ding; Malgorzata Chalimoniuk; Agnes Simonyi; Albert Y Sun; Zezong Gu; Gary A Weisman; W Gibson Wood; Grace Y Sun
Journal:  ASN Neuro       Date:  2011-02-08       Impact factor: 4.146

10.  Protein kinase D1 (PKD1) activation mediates a compensatory protective response during early stages of oxidative stress-induced neuronal degeneration.

Authors:  Arunkumar Asaithambi; Arthi Kanthasamy; Hariharan Saminathan; Vellareddy Anantharam; Anumantha G Kanthasamy
Journal:  Mol Neurodegener       Date:  2011-06-22       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.